<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine tissue factor procoagulant activity (TF-<z:chebi fb="20" ids="36751">PCA</z:chebi>) in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and to examine effects of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> plus <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> on TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We have determined circulating TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> and other coagulation factors under basal (hyperglycemic) conditions, after <z:hpo ids='HP_0011009'>acute</z:hpo> correction of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, in response to 24 h of selective <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, and in response to 24 h of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> plus <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> in nine type 1 diabetic patients and in seven nondiabetic control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: As shown previously in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, basal TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> and plasma coagulation factor VIIa (FVIIa) were higher in patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> than in nondiabetic control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>However, in contrast with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, normalizing <z:chebi fb="105" ids="17234">glucose</z:chebi> did not decrease the elevated TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> levels, and raising <z:chebi fb="105" ids="17234">glucose</z:chebi> or <z:chebi fb="105" ids="17234">glucose</z:chebi> plus insulin levels did not increase TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Patients with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> have elevated circulating TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> and FVIIa levels and are in a procoagulant state that may predispose them to <z:hpo ids='HP_0011009'>acute</z:hpo> cardiovascular events </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanisms regulating TF-<z:chebi fb="20" ids="36751">PCA</z:chebi> in patients with type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are different and should be further explored </plain></SENT>
</text></document>